Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.81 USD | -0.41% |
|
-1.70% | -6.48% |
29/05 | Veradigm to Explore Strategic Alternatives | CI |
28/05 | Veradigm Inc. Is Reaffirms Earnings Guidance for Fiscal 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.48% | 166.3Cr | |
-5.50% | 3.03TCr | |
+40.35% | 946.53Cr | |
+31.81% | 432.89Cr | |
-36.88% | 249.08Cr | |
-23.84% | 126.57Cr | |
-42.92% | 97Cr | |
-3.96% | 89Cr | |
-50.69% | 69Cr | |
-29.70% | 61Cr |
- Stock Market
- Equities
- MDRX Stock
- News Veradigm Inc.
- Goldman Sachs Upgrades Allscripts Healthcare Solutions to Buy From Neutral, Adjusts Price Target to $23 From $22